{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:19:13Z","timestamp":1775542753024,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/nm1672","type":"journal-article","created":{"date-parts":[[2007,12,2]],"date-time":"2007-12-02T14:20:09Z","timestamp":1196605209000},"page":"1496-1503","source":"Crossref","is-referenced-by-count":460,"title":["PPAR-\u03b3 regulates osteoclastogenesis in mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Yihong","family":"Wan","sequence":"first","affiliation":[]},{"given":"Ling-Wa","family":"Chong","sequence":"additional","affiliation":[]},{"given":"Ronald M","family":"Evans","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,12,2]]},"reference":[{"key":"BFnm1672_CR1","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1056\/NEJMra040952","volume":"351","author":"J Tolar","year":"2004","unstructured":"Tolar, J., Teitelbaum, S.L. & Orchard, P.J. Osteopetrosis. N. Engl. J. Med. 351, 2839\u20132849 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1672_CR2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI200419900","volume":"113","author":"T Akune","year":"2004","unstructured":"Akune, T. et al. PPAR \u03b3 insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J. Clin. Invest. 113, 846\u2013855 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnm1672_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/sj.embor.7400254","volume":"5","author":"TA Cock","year":"2004","unstructured":"Cock, T.A. et al. Enhanced bone formation in lipodystrophic PPAR\u03b3hyp\/hyp mice relocates haematopoiesis to the spleen. EMBO Rep. 5, 1007\u20131012 (2004).","journal-title":"EMBO Rep."},{"key":"BFnm1672_CR4","doi-asserted-by":"crossref","unstructured":"Grey, A. Skeletal consequences of thiazolidinedione therapy. Osteoporos. Int. published online, doi:10.1007\/s00198-007-0477-y (28 September 2007).","DOI":"10.1007\/s00198-007-0477-y"},{"key":"BFnm1672_CR5","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn, S.E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N. Engl. J. Med. 355, 2427\u20132443 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1672_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis, A.E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443\u2013448 (1994).","journal-title":"Science"},{"key":"BFnm1672_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1097-2765(00)80209-9","volume":"4","author":"Y Barak","year":"1999","unstructured":"Barak, Y. et al. PPAR \u03b3 is required for placental, cardiac, and adipose tissue development. Mol. Cell 4, 585\u2013595 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1672_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","volume":"4","author":"N Kubota","year":"1999","unstructured":"Kubota, N. et al. PPAR \u03b3 mediates high-fat diet\u2013induced adipocyte hypertrophy and insulin resistance. Mol. Cell 4, 597\u2013609 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1672_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","volume":"4","author":"ED Rosen","year":"1999","unstructured":"Rosen, E.D. et al. PPAR \u03b3 is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611\u2013617 (1999).","journal-title":"Mol. Cell"},{"key":"BFnm1672_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1210\/en.2004-0735","volume":"146","author":"AA Ali","year":"2005","unstructured":"Ali, A.A. et al. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 146, 1226\u20131235 (2005).","journal-title":"Endocrinology"},{"key":"BFnm1672_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.bone.2006.04.008","volume":"39","author":"M Li","year":"2006","unstructured":"Li, M. et al. Surface-specific effects of a PPAR\u03b3 agonist, darglitazone, on bone in mice. Bone 39, 796\u2013806 (2006).","journal-title":"Bone"},{"key":"BFnm1672_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1210\/en.2003-0746","volume":"145","author":"SO Rzonca","year":"2004","unstructured":"Rzonca, S.O., Suva, L.J., Gaddy, D., Montague, D.C. & Lecka-Czernik, B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145, 401\u2013406 (2004).","journal-title":"Endocrinology"},{"key":"BFnm1672_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00223-004-0224-8","volume":"75","author":"V Sottile","year":"2004","unstructured":"Sottile, V., Seuwen, K. & Kneissel, M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif. Tissue Int. 75, 329\u2013337 (2004).","journal-title":"Calcif. Tissue Int."},{"key":"BFnm1672_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/dbio.2000.0106","volume":"230","author":"YY Kisanuki","year":"2001","unstructured":"Kisanuki, Y.Y. et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230\u2013242 (2001).","journal-title":"Dev. Biol."},{"key":"BFnm1672_CR15","doi-asserted-by":"publisher","first-page":"15712","DOI":"10.1073\/pnas.2536828100","volume":"100","author":"W He","year":"2003","unstructured":"He, W. et al. Adipose-specific peroxisome proliferator\u2013activated receptor \u03b3 knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100, 15712\u201315717 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1672_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/gene.1030","volume":"30","author":"R Constien","year":"2001","unstructured":"Constien, R. et al. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30, 36\u201344 (2001).","journal-title":"Genesis"},{"key":"BFnm1672_CR17","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.1567207","volume":"21","author":"Y Wan","year":"2007","unstructured":"Wan, Y. et al. Maternal PPAR \u03b3 protects nursing neonates by suppressing the production of inflammatory milk. Genes Dev. 21, 1895\u20131908 (2007).","journal-title":"Genes Dev."},{"key":"BFnm1672_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S1074-7613(00)80665-2","volume":"9","author":"N Takakura","year":"1998","unstructured":"Takakura, N. et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9, 677\u2013686 (1998).","journal-title":"Immunity"},{"key":"BFnm1672_CR19","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1038\/sj.onc.1205326","volume":"21","author":"AB Cantor","year":"2002","unstructured":"Cantor, A.B. & Orkin, S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 21, 3368\u20133376 (2002).","journal-title":"Oncogene"},{"key":"BFnm1672_CR20","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1182\/blood-2004-06-2480","volume":"105","author":"RS Taichman","year":"2005","unstructured":"Taichman, R.S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem cell niche. Blood 105, 2631\u20132639 (2005).","journal-title":"Blood"},{"key":"BFnm1672_CR21","doi-asserted-by":"publisher","first-page":"9416","DOI":"10.1073\/pnas.1533500100","volume":"100","author":"H Kawano","year":"2003","unstructured":"Kawano, H. et al. Suppressive function of androgen receptor in bone resorption. Proc. Natl. Acad. Sci. USA 100, 9416\u20139421 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1672_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","volume":"2","author":"G Karsenty","year":"2002","unstructured":"Karsenty, G. & Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389\u2013406 (2002).","journal-title":"Dev. Cell"},{"key":"BFnm1672_CR23","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","volume":"289","author":"SL Teitelbaum","year":"2000","unstructured":"Teitelbaum, S.L. Bone resorption by osteoclasts. Science 289, 1504\u20131508 (2000).","journal-title":"Science"},{"key":"BFnm1672_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17\u201325 (2006).","journal-title":"Trends Mol. Med."},{"key":"BFnm1672_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/72855","volume":"24","author":"K Matsuo","year":"2000","unstructured":"Matsuo, K. et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24, 184\u2013187 (2000).","journal-title":"Nat. Genet."},{"key":"BFnm1672_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","volume":"391","author":"M Ricote","year":"1998","unstructured":"Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator\u2013activated receptor-\u03b3 is a negative regulator of macrophage activation. Nature 391, 79\u201382 (1998).","journal-title":"Nature"},{"key":"BFnm1672_CR27","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1021\/bi0159581","volume":"41","author":"LM Leesnitzer","year":"2002","unstructured":"Leesnitzer, L.M. et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41, 6640\u20136650 (2002).","journal-title":"Biochemistry"},{"key":"BFnm1672_CR28","doi-asserted-by":"publisher","first-page":"19649","DOI":"10.1074\/jbc.M200743200","volume":"277","author":"G Lee","year":"2002","unstructured":"Lee, G. et al. T0070907, a selective ligand for peroxisome proliferator-activated receptor \u03b3, functions as an antagonist of biochemical and cellular activities. J. Biol. Chem. 277, 19649\u201319657 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnm1672_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1210\/jc.2006-2646","volume":"92","author":"A Grey","year":"2007","unstructured":"Grey, A. et al. The peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J. Clin. Endocrinol. Metab. 92, 1305\u20131310 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnm1672_CR30","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1172\/JCI24130","volume":"115","author":"PC Chui","year":"2005","unstructured":"Chui, P.C., Guan, H.P., Lehrke, M. & Lazar, M.A. PPAR\u03b3 regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J. Clin. Invest. 115, 2244\u20132256 (2005).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1672","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1672.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:30:14Z","timestamp":1684434614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BFnm1672"],"URL":"https:\/\/doi.org\/10.1038\/nm1672","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1097741.553858","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1097741.555108","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1097741.553831","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1097741.565516","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}